fbpx
  • About us
  • Advertise
  • Contact
  • Nominate
  • Client’s Voice
  • Login
  • Register
📖 Magazine
The Global Economics
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
The Global Economics
No Result
View All Result
Home Infrastructure Healthcare

WTO approves new vaccine-patent waiver to help combat Covid Pandemic: June 2022

The decision may not affect manufacturers adversely due to the glut in vaccine supply

Ritu M R by Ritu M R
June 17, 2022
in Healthcare, The Global Economics, Top Stories
Reading Time: 2 mins read
0
WTO approves new vaccine-patent waiver to help combat Covid Pandemic: June 2022

WTO approves new vaccine-patent waiver to help combat Covid Pandemic: June 2022

30
SHARES
169
VIEWS
FacebookTwitterRedditWhatsAppLinkedInShare Link

After an effort of almost two years, involving scores of high-level meetings and much political pressure the WTO (World Trade Organization) approved an important deal on Friday to dilute intellectual property restrictions for the manufacture of Covid-19 vaccines

During a meeting in Geneva, the WTO ministers approved a package of agreements that involved the vaccine patent waiver, which Director-General Ngozi Okonjo-Iweala previously said was essential to end the morally unacceptable inequity of access to Covid-19 vaccines.

The WTO’s last-minute deal secured an overnight negotiating session in Geneva. This is an important victory for the vaccine alliance by Okonjo-Iweala, the former head of Gavi, who actively campaigned for the deal during her first year as the WTO’s top trade official.

However, the deal brings a vital blow to vaccine manufacturers such as Moderna Inc., Pfizer Inc., and AstraZeneca Plc, who fought hard to prevent nations from undermining the intellectual-property framework that allowed them to harvest multiple viable Covid-19 vaccines in record time saving countless lives across the world.

Thomas Cueni, the director-general of the International Federation of Pharmaceutical Manufacturers and Associations said, the premise of an intellectual-property waiver for Covid-19 vaccines was flawed from the onset. He further added that to this day there is no evidence that IP has been a barrier to Covid-19 vaccine access or production.

The debate overcame an extended fight between the US and China over the Biden administration’s demand that China be excluded from the deal for fear that it would enable China to steal US technologies.

Vaccine glut makes WTO waiver unnecessary tool to fight Covid-19

Vaccines have become a crisis for trade protectionism and many US policymakers would want to prevent China from gaining access to the mRNA technology that Moderna, Pfizer and BioNTech SE used to produce Covid-19 vaccinations.

Though the Biden government supported the idea of waiving IP rights for a vaccine, it never displayed full support for the deal until it emerged in Geneva. The deal is likely to result in heavy political blowback from the US pharmaceutical sector and from Republican lawmakers who could oppose it.

Earlier during the month, US Trade Representative Katherine Tai found herself targeted by her former Capitol Hill colleagues for negotiating a back-room deal that many lawmakers speculated would undermine American innovation.

Excess Doses

 Eventually, as there is a global gut in the vaccines, the negotiation took a long time and the worldwide vaccine manufacturing effort worked so fast that the WTO’s final deal will not have a meaningful impact on the production of Covid-19 vaccines.

According to data from the European Federation of Pharmaceutical Industries and Associations, for the month of May, there were 2.1 billion excess doses of Covid-19 vaccines and their production has consistently outperformed the number of doses administered.

Chad Brown, a senior fellow at the Peterson Institute for International Economics stated that there is no longer a supply-side constraint on the availability of vaccines.

 

 

 

Via: short URL
Tags: COVID-19IPVaccineWTO
Ritu M R

Ritu M R

Ritu is a professional who aims at writing informative and engaging articles that appeal to the readers.

Related Posts

Swappable Batteries of Electric Scooter
The Global Economics

Can Swappable Batteries For EVs Work? Singapore’s Mo Batteries Is Hopeful

by Marifur Rahman
February 6, 2023
Meta shares increase the most since 2013 and earns $40 billion in share buybacks
Finance

Meta shares increase the most since 2013 and earns $40 billion in share buybacks

by Riya Thomas
February 3, 2023
Subway
The Global Economics

Sandwich Chain, Subway’s Business Becomes Tastier As Sales Climb

by Marifur Rahman
February 3, 2023
Saudi Arabia and Oman Sign 13 Investment Agreements of Value exceeding SAR 1bn
Energy

Saudi Arabia and Oman Sign 13 Investment Agreements of Value exceeding SAR 1bn

by Anuj Singh
February 3, 2023
Bank of England plans for its 10th successive interest-rate hike, stiffens for shallow recession
Funds

Bank of England plans for its 10th successive interest-rate hike, stiffens for shallow recession

by Riya Thomas
February 2, 2023
Facebook Twitter Instagram Youtube LinkedIn Soundcloud
The Global Economics

The Global Economics Limited is a UK based financial publication and a quarterly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

DMCA.com Protection Status

  • Privacy
  • Legal
  • Terms of Use
  • Client’s Voice
  • Server Status

norton verified - the global economics

Latest Posts

Swappable Batteries of Electric Scooter

Can Swappable Batteries For EVs Work? Singapore’s Mo Batteries Is Hopeful

February 6, 2023
Meta shares increase the most since 2013 and earns $40 billion in share buybacks

Meta shares increase the most since 2013 and earns $40 billion in share buybacks

February 3, 2023
Subway

Sandwich Chain, Subway’s Business Becomes Tastier As Sales Climb

February 3, 2023
Download The Global Economics PWA to your mobile or Desktop
PWA App Download
Download The Global Economics Android App to your mobile or Desktop
Android App
Download The Global Economics IOS App to your mobile or Desktop
IOS App

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

No Result
View All Result
  • About us
  • Awards
  • Magazine
  • Client’s Voice
  • Exclusive Coverage
  • Nominate
  • Login
  • Sign Up

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

Welcome Back!

Sign In with Facebook
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Linked In
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about new articles, delivered right into your email inbox.

-
00:00
00:00

Queue

Update Required Flash plugin
-
00:00
00:00
Go to mobile version